@article{dp697,
  title={Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results},
  author={},
  journal={The Clinical Lung Cancer},
  year={2026},
  doi={10.52338/tclc.2024.1002}
}